目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Indication
1.2.2. Drug Class
1.2.3. Route of Administration
1.2.4. Distribution Channel
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Indication and drug class outlook
2.2.2. Route of administration and distribution channel outlook
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Dementia Treatment Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of dementia
3.2.1.2. Increasing government funding and awareness programs
3.2.1.3. Surge in R&D activities
3.2.2. Market Restraint Analysis
3.2.2.1. High failure rates of drugs at approval stages
3.3. Dementia Treatment Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Dementia Treatment Market: Indication Estimates & Trend Analysis
4.1. Global Dementia Treatment Market: Indication Dashboard
4.2. Global Dementia Treatment Market: Indication Movement Analysis
4.3. Global Dementia Treatment Market by Indication, Revenue 2018 - 2030 (USD Million)
4.4. Alzheimer’s Disease Dementia
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Vascular Dementia
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Lewy Body Dementia
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Frontotemporal Dementia (FTD)
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Parkinson's Disease Dementia
4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Others
4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Dementia Treatment Market: Drug Class Estimates & Trend Analysis
5.1. Global Dementia Treatment Market: Drug Class Dashboard
5.2. Global Dementia Treatment Market: Drug Class Movement Analysis
5.3. Global Dementia Treatment Market by Drug Class, Revenue 2018 - 2030 (USD Million)
5.4. Cholinesterase Inhibitors
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. NMDA Receptor Antagonist
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. MAO Inhibitors
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Combination Drug
5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Others
5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Dementia Treatment Market: Route of Administration Estimates & Trend Analysis
6.1. Global Dementia Treatment Market: Route of Administration Dashboard
6.2. Global Dementia Treatment Market: Route of Administration Movement Analysis
6.3. Global Dementia Treatment Market by Route of Administration, Revenue 2018 - 2030 (USD Million)
6.4. Oral
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Transdermal Patch
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Injectable
6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Dementia Treatment Market: Distribution Channel Estimates & Trend Analysis
7.1. Global Dementia Treatment Market: Distribution Channel Dashboard
7.2. Global Dementia Treatment Market: Distribution Channel Movement Analysis
7.3. Global Dementia Treatment Market by Distribution Channel, Revenue 2018 - 2030 (USD Million)
7.4. Hospital Pharmacy
7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Retail Pharmacy
7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Online Pharmacy
7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Dementia Treatment Market: Regional Estimates & Trend Analysis by Indication, Drug Class, Route of Administration, and Distribution hannel
8.1. Regional Dashboard
8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.3. North America
8.3.1. U.S.
8.3.1.1. Key country dynamics
8.3.1.2. Regulatory framework/ reimbursement structure
8.3.1.3. Competitive scenario
8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.3.2. Canada
8.3.2.1. Key country dynamics
8.3.2.2. Regulatory framework/ reimbursement structure
8.3.2.3. Competitive scenario
8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Germany
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. France
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.4.4. Italy
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.4.5. Spain
8.4.5.1. Key country dynamics
8.4.5.2. Regulatory framework/ reimbursement structure
8.4.5.3. Competitive scenario
8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.4.6. Norway
8.4.6.1. Key country dynamics
8.4.6.2. Regulatory framework/ reimbursement structure
8.4.6.3. Competitive scenario
8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.4.7. Sweden
8.4.7.1. Key country dynamics
8.4.7.2. Regulatory framework/ reimbursement structure
8.4.7.3. Competitive scenario
8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.4.8. Denmark
8.4.8.1. Key country dynamics
8.4.8.2. Regulatory framework/ reimbursement structure
8.4.8.3. Competitive scenario
8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. China
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. India
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. Australia
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. South Korea
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Thailand
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Mexico
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. Argentina
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework/ reimbursement structure
8.6.3.3. Competitive scenario
8.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. UAE
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Kuwait
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.3.4. Eisai Co., Ltd.
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Lilly
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Novartis AG
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. DAIICHI SANKYO COMPANY, LIMITED
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. AbbVie Inc.
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. H. Lundbeck A/S
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Biogen
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Cipla Inc.
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Sun Pharmaceutical Industries Ltd.
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Viatris Inc.
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Product benchmarking
9.3.13.4. Strategic initiatives

List of Tables
Table 1 List of abbreviation
Table 2 North America dementia treatment market, by country, 2018 - 2030 (USD Million)
Table 3 North America dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 4 North America dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 5 North America dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 6 North America dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 7 U.S. dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 8 U.S. dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 9 U.S. dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 10 U.S. dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 11 Canada dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 12 Canada dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 13 Canada dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 14 Canada dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 15 Europe dementia treatment market, by country, 2018 - 2030 (USD Million)
Table 16 Europe dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 17 Europe dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 18 Europe dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 19 Europe dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 20 Germany dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 21 Germany dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 22 Germany dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 23 Germany dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 24 UK dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 25 UK dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 26 UK dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 27 UK dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 28 France dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 29 France dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 30 France dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 31 France dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 32 Italy dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 33 Italy dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 34 Italy dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 35 Italy dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 36 Spain dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 37 Spain dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 38 Spain dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 39 Spain dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 40 Denmark dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 41 Denmark dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 42 Denmark dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 43 Denmark dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 44 Sweden dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 45 Sweden dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 46 Sweden dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 47 Sweden dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 48 Norway dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 49 Norway dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 50 Norway dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 51 Norway dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 52 Asia Pacific dementia treatment market, by region, 2018 - 2030 (USD Million)
Table 53 Asia Pacific dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 54 Asia Pacific dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 55 Aisa Pacific dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 56 Aisa Pacific dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 57 China dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 58 China dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 59 China dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 60 China dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 61 Japan dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 62 Japan dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 63 Japan dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 64 Japan dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 65 India dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 66 India dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 67 India dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 68 India dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 69 South Korea dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 70 South Korea dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 71 South Korea dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 72 South Korea dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 73 Australia dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 74 Australia dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 75 Australia dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 76 Australia dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 77 Thailand dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 78 Thailand dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 79 Thailand dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 80 Thailand dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 81 Latin America dementia treatment market, by region, 2018 - 2030 (USD Million)
Table 82 Latin America dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 83 Latin America dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 84 Latin America dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 85 Latin America dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 86 Brazil dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 87 Brazil dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 88 Brazil dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 89 Brazil dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 90 Mexico dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 91 Mexico dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 92 Mexico dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 93 Mexico dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 94 Argentina dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 95 Argentina dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 96 Argentina dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 97 Argentina dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 98 MEA dementia treatment market, by region, 2018 - 2030 (USD Million)
Table 99 MEA dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 100 MEA dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 101 MEA dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 102 MEA dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 103 South Africa dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 104 South Africa dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 105 South Africa dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 106 South Africa dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 111 UAE dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 112 UAE dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 113 UAE dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 114 UAE dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 115 Kuwait dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 116 Kuwait dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 117 Kuwait dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 118 Kuwait dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Dementia treatment market: market outlook
Fig. 14 Dementia treatment competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Dementia treatment market driver impact
Fig. 18 Dementia treatment market restraint impact
Fig. 19 Dementia treatment market: Indication movement analysis
Fig. 20 Dementia treatment market: Indication outlook and key takeaways
Fig. 21 Alzheimer’s disease dementia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Vascular dementia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Lewy body dementia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Frontotemporal dementia (FTD) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Parkinson'skinson disease dementia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Dementia treatment market: Drug class movement analysis
Fig. 28 Dementia treatment market: Drug class outlook and key takeaways
Fig. 29 Cholinesterase inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 NMDA receptor antagonist market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 MAO inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Combination drug market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Dementia treatment market: Route of administration movement analysis
Fig. 35 Dementia treatment market: Route of administration outlook and key takeaways
Fig. 36 Oral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Transdermal patch market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Dementia treatment market: Distribution channel movement analysis
Fig. 40 Dementia treatment market: Distribution channel outlook and key takeaways
Fig. 41 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Global dementia treatment market: Regional movement analysis
Fig. 45 Global dementia treatment market: Regional outlook and key takeaways
Fig. 46 Global dementia treatment market share and leading players
Fig. 47 North America, by country
Fig. 48 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 U.S. key country dynamics
Fig. 50 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Canada key country dynamics
Fig. 52 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 UK key country dynamics
Fig. 55 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Germany key country dynamics
Fig. 57 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 France key country dynamics
Fig. 59 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Italy key country dynamics
Fig. 61 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Spain key country dynamics
Fig. 63 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Denmark key country dynamics
Fig. 65 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Sweden key country dynamics
Fig. 67 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Norway key country dynamics
Fig. 69 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 China key country dynamics
Fig. 72 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Japan key country dynamics
Fig. 74 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 India key country dynamics
Fig. 76 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Thailand key country dynamics
Fig. 78 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 South Korea key country dynamics
Fig. 80 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Australia key country dynamics
Fig. 82 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Brazil key country dynamics
Fig. 85 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Mexico key country dynamics
Fig. 87 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Argentina key country dynamics
Fig. 89 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 South Africa key country dynamics
Fig. 92 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Saudi Arabia key country dynamics
Fig. 94 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 UAE key country dynamics
Fig. 96 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Kuwait key country dynamics
Fig. 98 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Market share of key market players- 2023